Form D · Other Health Care

Rapid Diagnostek, Inc.

Plymouth, MN · CIK 0001551344

Offering snapshot reported Mar 10, 2015 · SEC filing

Reported sold
$3.32M
Offering amount: $5.5M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 4, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 10, 2015Initial$3,318,748No comparison6SEC filing
Aug 1, 2013Initial$850,000No comparison3SEC filing
Jun 6, 2012Initial$4,635,000No comparison10SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$72.5K (estimated)
Finders' fees
$0
Form D file number
021-235523
3.5% of total gross proceeds to be received by the Company from the sale of the securities to the Investor solicited by the broker, less $50,000 retainer previously paid by the Company to the broker

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Needham & Company LLC16360Needham & Company LLC · CRD 16360

Source: Form D, filed Mar 10, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jack Ahrens Director
Steve Einhorn Director
Daniel Einhorn Director
Charlie Goff Director
Paul Knapp Director
Harry Norris Director, Executive
Lou Pollock Director
Brock Siegel Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
14505 21st Avenue N. Suite 212
Plymouth, MN, 55447